Ocugen CEO Musunuri moderates H.C. Wainwright Biotech on Tap panel
OCGN•Ocugen CEO Shankar Musunuri will participate in two October conferences, moderating a structured finance panel in Munich on Oct. 1 and speaking about approval and commercialization paths in Phoenix on Oct. 6.
1. October conference appearances
Musunuri is scheduled to moderate a structured finance panel at H.C. Wainwright’s Biotech on Tap in Munich on Oct. 1, 2026. On Oct. 6, he is scheduled to speak about approval and commercialization paths at Cell & Gene Meeting on the Mesa in Phoenix.
